Gem Pharmaceuticals, LLC (GEM)

Oncology Corporate Profile

HQ Location

941 Lake Forest Circle
Birmingham, AL 35244

Company Description

Gem Pharmaceuticals is a clinical-stage biopharmaceutical company developing proprietary anthracycline derivatives specifically designed to eliminate the critical cardiotoxicity side effect of this powerful class of chemotherapeutics while maintaining their well-documented anti-cancer efficacy.

Website: http://www.gempharmaceuticals.com/

This company does not have any commercial products
  • Brand
  • Generic
  • Investigational
Brand / Product Class Area of Study Phase Partnership
GPX-150anthracycline compoundVarious cancer typesINULl

View additional information on product candidates here »

Source


http://www.gempharmaceuticals.com/

Recent News Headlines

Results - Singapore Rough Ruby Auction

12/19/2016 07:01 am

[at noodls] - Gemfields plc ('Gemfields' or 'the Company') 19 December 2016 Gemfields plc (AIM: GEM) is pleased to announce the results of its auction of rough ruby extracted by Montepuez Ruby Mining Limitada (which ...

Update to December 2016 Emerald Auction

12/1/2016 03:02 pm

[at noodls] - Gemfields plc ('Gemfields' or the 'Company') 1 December 2016 Gemfields plc (AIM: GEM) announces that its auction of predominantly higher quality emeralds from the Kagem emerald mine in Zambia, originally ...

Change in registered office address

12/1/2016 03:02 pm

[at noodls] - Gemfields plc ('Gemfields' or the 'Company') 30 November 2016 Gemfields plc (AIM: GEM) announces that the Company's registered office address has changed from 23 King Street, London, SW1Y 6QY to 1 New ...

Result of AGM

11/30/2016 05:03 am

[at noodls] - Gemfields plc ('Gemfields' or the 'Company') 24 November 2016 Gemfields plc (AIM: GEM) is pleased to announce that at the Annual General Meeting ('AGM') of the Company held today, all resolutions were ...

Grant of Share Options

11/10/2016 05:05 pm

[at noodls] - Gemfields plc ('Gemfields' or the 'Company') 10 November 2016 Gemfields (AIM: GEM) announces that it has granted to certain directors and employees a total of 6,715,000 options over ordinary shares of ...

Board changes

11/1/2016 12:01 pm

[at noodls] - Gemfields plc ('Gemfields' or the 'Company') 1 November 2016 Gemfields plc (AIM: GEM) is pleased to announce that, further to the announcement of 18 October 2016, the Company has appointed Janet Boyce ...

Market Update - Quarter to 30 September 2016

11/1/2016 07:01 am

[at noodls] - Gemfields plc ('Gemfields' or the 'Company') 1 November 2016 Gemfields plc (AIM: GEM) is pleased to present an operational update for the three month period ending 30 September 2016, the first quarter ...

Notice of 2016 Annual General Meeting

10/28/2016 06:00 am

[at noodls] - Gemfields plc ('Gemfields' or the 'Company') 28 October 2016 Gemfields plc (AIM: GEM) announces that the Company's Annual General Meeting will be held at 11.00 a.m. (GMT) on Thursday, 24 November 2016 ...

Changes to Board of Directors

10/18/2016 02:05 pm

[at noodls] - Gemfields plc ('Gemfields' or 'the Company') 18 October 2016 Gemfields plc announces the resignation of COO, Devidas Shetty, who will leave the Gemfields Group and step down from the board of directors ...

Capital Markets Day

10/13/2016 06:01 am

[at noodls] - Gemfields plc ('Gemfields' or the 'Company') 13 October 2016 Gemfields plc (AIM: GEM), the leading supplier of responsibly sourced coloured gemstones, is holding its first for analysts and institutional ...

QOPI Participation Leads to Improved Assessment and Management of Opioid-Associated Constipation

10/5/2016 11:25 am

(ASCO in Action) Oct 4, 2016 - A new article in the Journal of Oncology Practice (JOP) used data from ASCO’s Quality Oncology Practice Initiative (QOPI®) to improve assessment and management of opioid-associated constipation (OAC).

Final audited results for the year to 30 June 2016

9/26/2016 06:00 am

[at noodls] - Gemfields plc ('Gemfields' or the 'Company' or the 'Group') (AIM: GEM) Final audited results for the year ended 30 June 2016 26 September 2016 Financial Highlights · Revenue of US$193.1 million (2015: ...

Navigating Cancer Unveils Patient Relationship Management Platform

9/15/2016 12:06 pm

(TheStreet) Sept 15, 2016 - New platform is the most comprehensive patient-centered operating system available for oncology clinics.

Notice of Final Results

9/13/2016 06:00 am

[at noodls] - Gemfields plc ('Gemfields' or the 'Company') 13 September 2016 Gemfields plc (AIM: GEM), the leading supplier of responsibly sourced coloured gemstones, will be reporting its final results for the year ...

TARIS Biomedical® Launches Second Phase 1b Clinical Trial of TAR-200 (GemRIS™) in Patients with Bladder Cancer

8/10/2016 11:10 am

(PipelineReview.com) Aug 10, 2016 - TARIS Biomedical announced today the initiation of a Phase 1b clinical trial of TAR-200 (GemRIS™, Gemcitabine Releasing Intravesical System) in patients with non-muscle-invasive bladder cancer (NMIBC).

Market Update - Quarter to 30 June 2016

8/1/2016 06:01 am

[at noodls] - Gemfields plc ('Gemfields' or the 'Company') 1 August 2016 Gemfields plc (AIM: GEM) is pleased to present an operational update for the three month period ending 30 June 2016, the fourth quarter of the ...

Block Listing Six Monthly Return

7/29/2016 09:05 am

[at noodls] - Gemfields plc 29 July 2016 Name of scheme: Employee Share Option Scheme Period of return: 27 January 2016 - 26 July 2016 ... This is an abstract of the original noodl. To continue reading this document, ...

Management of Chronic Pain in Survivors of Adult Cancers

7/26/2016 11:16 am

(ASCO) July 25, 2016 - Purpose: To provide evidence-based guidance on the optimum management of chronic pain in adult cancer survivors.

Chopard and Gemfields create a new industry-leading partnership

7/26/2016 09:05 am

[at noodls] - faf1b47c-c174-440a-a4de-02d259aa9f71.pdf Chopard's 'Journey to Sustainable Luxury' continues with the announcement of a new milestone for coloured gemstones at the 2016 Cannes Film Festival Chopard is ...

Study Shows Doctor Engagement Critical For Obama To Reach His Health Reform Goals

7/13/2016 11:01 am

(Forbes) July 12, 2016 - It’s clear that doctors, not health systems, are central to driving the revolution in healthcare.

Sun Pharma Launches Gemcitabine InfuSMART, World's First Licensed Ready-to-administer Bag for Oncology Treatment

7/11/2016 10:13 am

(The Business Journals) July 11, 2016 - As part of its business strategy to build a meaningful and differentiating presence in Global Oncology Therapy market, Sun Pharma today announced the roll-out of Gemcitabine InfuSMART in Europe. InfuSMART is a technology in which oncology products are developed in a Ready-To-Administer (RTA) bag.

ESMO Releases New Consensus Guidelines on the Management of Metastatic Colorectal Cancer

7/6/2016 12:16 pm

(ESMO) July 6, 2016 - ESMO, the leading European professional organisation for medical oncology, has released new consensus guidelines for the management of metastatic colorectal cancer that reflect an increasingly personalized approach to treatment, as published online today in Annals of Oncology(1).

USD 65 million debt financing facilities

7/4/2016 06:01 am

[at noodls] - Gemfields plc ('Gemfields' or 'the Company') 04 July 2016 Gemfields plc (AIM: GEM) is pleased to announce the finalisation of four debt financing facilities (the 'Facilities'). Following evaluation of ...

EMA and FDA Begin Collaborations on Patient Engagement

6/23/2016 11:48 am

(Regulatory Affairs) June 22, 2016 - The European Medicines Agency (EMA) and the US Food and Drug Administration (FDA) on Wednesday began exchanging more information on the best practices of involving patients in the development, evaluation and post-authorization tracking of medicines.

Results - Singapore Rough Ruby Auction

6/20/2016 06:00 am

[at noodls] - Gemfields plc ('Gemfields' or 'the Company') 20 June 2016 Gemfields plc (AIM: GEM) is pleased to announce the results of its auction of rough ruby extracted by Montepuez Ruby Mining Limitada (which is ...

ASCO Issues Guidelines for Pancreatic Cancer Management

6/13/2016 12:12 pm

(Medscape Medical News) June 13, 2016 - Now the American Society of Clinical Oncology (ASCO) has issued a series of guidelines on the management of all stages of this doleful malignancy.